• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Boston Scientific continues to make progress on cyberattack recovery

Boston Scientific continues to make progress on cyberattack recovery

September 11, 2026 By Chris Newmarker

This is the logo of Boston Scientific.Boston Scientific (NYSE: BSX) announced on LinkedIn that it has now fully restored manufacturing, order fulfillment and shipping operations after a cybersecurity incident identified on Aug. 25.

In the LinkedIn post, out yesterday, the Marlborough, Massachusetts–based minimally invasive medtech company said: “As order processing continues, we are working to fulfill customer orders as quickly as possible. While some customers may continue to experience temporary delays, we are prioritizing manufacturing and distribution efforts to support ongoing customer demand and minimize the impact on patients and healthcare providers.”

In an accompanying video, CEO Mike Mahoney described the development as a significant milestone.

“Our operating capacity continues to rapidly increase, and our products are moving through our distribution network at or above normal levels,” Mahoney said. “And our teams continue to work around the clock to fulfill customer orders, reduce backlogs, and accelerate the delivery of products to customers and the patients who depend on them the most.

“I’ve talked many times about the winning spirit of Boston Scientific. It’s easy to talk about when things are going well, but moments like this show what it really means. It means staying focused when the path isn’t easy, being agile, helping one another, and doing whatever we can to deliver for patients and customers.”

Earlier this week, Boston Scientific said the cybersecurity incident will make it unlikely to meet previously set full-year guidance. It’s still uncertain when operations will be fully restored.

BSX shares are down more than 8% over the past five days, trading around $43 apiece.

The cybersecurity incident is the latest in a string of cybersecurity incidents that medical device companies have disclosed this year. Earlier this year, an Iran-backed cyberattack effectively wiped out data on Stryker’s Microsoft-based IT system, with the ortho and surgical devices company still working through some after-effects. Medtronic, Intuitive, Novocure, and iRhythm have also reported cybersecurity incidents.

Filed Under: Business/Financial News, Wall Street Beat Tagged With: Boston Scientific, Cybersecurity

More recent news

  • Boston Scientific continues to make progress on cyberattack recovery
  • Edwards Lifesciences, Medtronic score CMS win over TAVR
  • Stryker still working through cyberattack after-effects, stock down more than 10% this week
  • Siemens Healthineers completes $44M R&D, manufacturing site expansion
  • Next-gen Apple Watch Ultra 4 includes new health features

About Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy